In the article “Top Global Agriculture Picks” which companies did Victor Badin recommend?

In a time of rising food prices, investors should have agricultural stocks in their portfolios, Victor Badin, fund manager at Global Cap, said.

And China Farm Equipment, Bunge and Myriya Agro Holdings are among the most attractive of the bunch, Badin said.

Bunge (BG) gets high marks for earnings momentum and price momentum in the models I follow. However, its free cash flow ranking is low.

Sponsor: Financial Education Everything you need to know about finance

The Dow has been hit hard with selling, breaking through the key 11,600 support level I’ve been warning about. I said that once the Dow breaks 11,600, the bear is back in control and much lower prices are to come. That means U.S. stocks, and by default the U.S. economy, are going over the cliff. How low will it go? We need more fear in the market before a bottom comes and I see the Dow dropping to as low as 9,200 before a turnaround starts to take hold. Of course, it won't be a straight-down affair. There will be a lot of fake-out moves and with all the uncertainty out there, there will be a lot of volatility. The economic news is not good, and a lot of investors are very, very nervous, and rightfully so. What should you do? Be cautious. Stick ...

Middlebrook Pharmaceuticals discovered in 2000 that bacteria exposed to antibiotics in front-loaded, sequential bursts, or pulses, are killed more efficiently than those exposed to standard antibiotic treatment regimens. The company went on to develop novel anti-infective pulsatile drug products that take advantage of this discovery.

Middlebrook is applying their technology to drugs that may have lost their effectiveness in previous applications. The advantages of pulse therapy are: once-a-day formulation, lower dosages, shorter duration of therapy, reduced side effects, reduced incidence of resistance, combination products with superior efficacy over either product alone, and improved pediatric and geriatric dosages.

The $100M investment in Middlebrook should be exciting for investors. However, some Middlebrook investors were hoping for an outright buyout at $6 to $8 dollars a share by a larger pharmaceutical. This investment shows that the company is viable, and that a serious investment company such as Equity Group Investments, LLC would not have moved

...

Vanda Pharma (VNDA) and Titan Pharma (TTP) are a pair of biotech blow-ups which investors should avoid ahead of a July 27, 2008, PDUFA decision date for anti-psychotic drug Fanapta (iloperidone). Both stocks have lost about two-thirds of their market value over the last year and are down sharply recently on pipeline clinical trial failures. I don’t think the FDA will approve Fanapta as the anti-psychotic space already has plenty of similar options and thec agency is cracking down on the widespread, off-label use of these drugs in elderly patients.

Fellow Stockmasters, just came across this great article on the Motley Fool about Analyst estimates. Good read: It is a pervasive myth that has left the savings of countless small investors in ruins. More likely than not, it is a piece of information you've relied on while making ...

When I see other financial bloggers on sites like SeekingAlpha and StraightStocks I sometimes wonder who is tracking their picks and who is keeping them honest. Their picks don’t have a very good chance of paying off anytime in the next 6 months. And most investors will be selling an …

Boy, did Federal Reserve Chairman Ben Bernanke blow it this week! Investors were looking for a strong Fed statement because they believed it would support the dollar and snuff out the recent surge in commodities prices. But instead of reassuring Wall Street and giving investors an excuse to drive stocks through the roof, Bernanke blinked. Investors expressed their disapproval by responding with a strong statement of their own. The Dow's 358 point collapse yesterday can be directly traced back to ... The Fed is TALKING tough about inflation, but making it clear it isn't going to DO anything about it. Officials talked quite a bit about elevated inflation in their post-meeting statement. They said: "The Committee expects inflation to moderate later this year and next year. ...

We have heard alot of discussion lately in regards to why the miners could possibly be doing so horribly, when history has shown us that mining stocks should be skyrocketing given the last 8 year bull run in precious metals.

Two words: Naked Shorting

Jim Sinclair has created a movement lately asking to enlist over 200,000 investors, and thousands of mining companies, to put a stop to the criminal activity of Naked Shorting that literally steals money from investors.  You can see more information on Jim Sinclairs initiative here.

One of the best detailed audio explanations of how Naked Shorting works, listen to this audio program.

Hopefully when this all starts coming to light, the brokers who have engaged in this criminal activity will be spending a long time in a cold cell with a large room-mate named Bubba who finds ex-stock brokers attractive.

...

Barack Obama has offered new steps to crack down on speculation in oil markets, saying his plan would help rein in runaway fuel costs. Let's review the details of Obama's plan, which will benefit investors by Shorting DIG and going Long DUG: * The Illinois senator's campaign said he would close the so-called Enron loophole that exempts some energy speculators from U.S. regulations that apply to commodities traded over exchanges. It takes its name from the energy giant that benefited from the law and later collapsed because of massive accounting fraud. * His plan would require ...

Asia Time Corporation, a Chinese timepiece manufacturer, was featured in a trade alert issued today by Beacon Equity. The stock has traded from $4.50 to over $5.00 in just a few sessions, with indicators pointing toward a continuation of momentum.

The company’s first quarter financial results were impressive, showing a marked improvement across the board, as compared to those of a year ago. Revenues hit $36.8 million, with a net income of $2.4 million, greatly superseding last year’s Q1 revenues of $21.1 million, and net loss of $193,000.

With a market cap of a mere $126.8 million, Asia Time Corporation is a subject of intrigue for many investors, and appears to be building strength as a company at an alarming rate. According to the Beacon Equity report, “The company attributes the increases to a portfolio of diversified products with higher selling prices, flexible and extended credit terms, and a targeted

...